• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类器官囊泡发生揭示了微环境在人类多囊肾病中的关键作用。

Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease.

机构信息

Division of Nephrology, University of Washington School of Medicine, Seattle, Washington 98109, USA.

Kidney Research Institute, University of Washington School of Medicine, Seattle, Washington 98109, USA.

出版信息

Nat Mater. 2017 Nov;16(11):1112-1119. doi: 10.1038/nmat4994. Epub 2017 Oct 2.

DOI:10.1038/nmat4994
PMID:28967916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5936694/
Abstract

Polycystic kidney disease (PKD) is a life-threatening disorder, commonly caused by defects in polycystin-1 (PC1) or polycystin-2 (PC2), in which tubular epithelia form fluid-filled cysts. A major barrier to understanding PKD is the absence of human cellular models that accurately and efficiently recapitulate cystogenesis. Previously, we have generated a genetic model of PKD using human pluripotent stem cells and derived kidney organoids. Here we show that systematic substitution of physical components can dramatically increase or decrease cyst formation, unveiling a critical role for microenvironment in PKD. Removal of adherent cues increases cystogenesis 10-fold, producing cysts phenotypically resembling PKD that expand massively to 1-centimetre diameters. Removal of stroma enables outgrowth of PKD cell lines, which exhibit defects in PC1 expression and collagen compaction. Cyclic adenosine monophosphate (cAMP), when added, induces cysts in both PKD organoids and controls. These biomaterials establish a highly efficient model of PKD cystogenesis that directly implicates the microenvironment at the earliest stages of the disease.

摘要

多囊肾病(PKD)是一种危及生命的疾病,通常由多囊蛋白-1(PC1)或多囊蛋白-2(PC2)的缺陷引起,在这种疾病中,管状上皮形成充满液体的囊肿。了解 PKD 的主要障碍是缺乏能够准确有效地重现囊肿发生的人类细胞模型。此前,我们已经使用人类多能干细胞和衍生的肾脏类器官生成了 PKD 的遗传模型。在这里,我们表明系统替代物理成分可以显著增加或减少囊肿的形成,揭示了微环境在 PKD 中的关键作用。去除黏附线索可使囊肿形成增加 10 倍,产生类似于 PKD 的囊肿,其体积迅速扩大至 1 厘米直径。去除基质可使 PKD 细胞系生长,这些细胞系表现出 PC1 表达和胶原紧缩缺陷。添加环磷酸腺苷(cAMP)可诱导 PKD 类器官和对照物中的囊肿。这些生物材料建立了一种高效的 PKD 囊肿发生模型,直接涉及疾病早期的微环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91cc/5936694/76ede7fce1f9/nihms902934f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91cc/5936694/87067be19140/nihms902934f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91cc/5936694/d5a8c8514bff/nihms902934f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91cc/5936694/73bd3cfec9da/nihms902934f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91cc/5936694/d176b037ebdd/nihms902934f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91cc/5936694/76ede7fce1f9/nihms902934f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91cc/5936694/87067be19140/nihms902934f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91cc/5936694/d5a8c8514bff/nihms902934f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91cc/5936694/73bd3cfec9da/nihms902934f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91cc/5936694/d176b037ebdd/nihms902934f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91cc/5936694/76ede7fce1f9/nihms902934f5.jpg

相似文献

1
Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease.类器官囊泡发生揭示了微环境在人类多囊肾病中的关键作用。
Nat Mater. 2017 Nov;16(11):1112-1119. doi: 10.1038/nmat4994. Epub 2017 Oct 2.
2
Genetics of cystogenesis in base-edited human organoids reveal therapeutic strategies for polycystic kidney disease.碱基编辑人类类器官中的囊发生遗传学揭示了多囊肾病的治疗策略。
Cell Stem Cell. 2024 Apr 4;31(4):537-553.e5. doi: 10.1016/j.stem.2024.03.005.
3
Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease.在多囊肾病的人体芯片类器官模型中,葡萄糖吸收驱动囊肿形成。
Nat Commun. 2022 Dec 23;13(1):7918. doi: 10.1038/s41467-022-35537-2.
4
Mouse models of polycystic kidney disease induced by defects of ciliary proteins.由纤毛蛋白缺陷引起的多囊肾病的小鼠模型。
BMB Rep. 2013 Feb;46(2):73-9. doi: 10.5483/bmbrep.2013.46.2.022.
5
Acute kidney injury induces hallmarks of polycystic kidney disease.急性肾损伤诱发多囊肾病的特征。
Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F740-F751. doi: 10.1152/ajprenal.00167.2016. Epub 2016 Aug 3.
6
Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells.多囊蛋白-1改变了M-1细胞的cAMP生长反应表型。
Kidney Int. 2001 Aug;60(2):484-94. doi: 10.1046/j.1523-1755.2001.060002484.x.
7
Prothymosin α promotes STAT3 acetylation to induce cystogenesis in Pkd1-deficient mice.前胸腺素α通过促进 STAT3 乙酰化诱导 Pkd1 缺陷型小鼠的囊泡生成。
FASEB J. 2019 Nov;33(11):13051-13061. doi: 10.1096/fj.201900504R. Epub 2019 Oct 5.
8
Drug discovery for polycystic kidney disease.多囊肾病的药物发现。
Acta Pharmacol Sin. 2011 Jun;32(6):805-16. doi: 10.1038/aps.2011.29.
9
Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.腺苷酸环化酶5将钙稳态变化与多囊性肝病中依赖cAMP的囊肿生长联系起来。
J Hepatol. 2017 Mar;66(3):571-580. doi: 10.1016/j.jhep.2016.10.032. Epub 2016 Nov 5.
10
[Recent advances in molecular pathogenesis and treatment of polycystic kidney disease].[多囊肾病分子发病机制与治疗的最新进展]
Rev Med Chir Soc Med Nat Iasi. 2008 Jan-Mar;112(1):11-20.

引用本文的文献

1
Organoids in Genetic Disorders: from Disease Modeling to Translational Applications.遗传性疾病中的类器官:从疾病建模到转化应用
Stem Cell Rev Rep. 2025 Sep 11. doi: 10.1007/s12015-025-10973-x.
2
CRISPR and gene editing for kidney diseases: where are we?用于肾脏疾病的CRISPR与基因编辑:我们目前的进展如何?
Clin Kidney J. 2025 Jul 31;18(9):sfaf246. doi: 10.1093/ckj/sfaf246. eCollection 2025 Sep.
3
Modeling of kidney allograft rejection using hiPSC-derived kidney organoids and HLA-mismatched PBMCs: an in vitro co-culture system.

本文引用的文献

1
The Molecular Signatures Database (MSigDB) hallmark gene set collection.分子特征数据库(MSigDB)标志性基因集集合。
Cell Syst. 2015 Dec 23;1(6):417-425. doi: 10.1016/j.cels.2015.12.004.
2
Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids.利用源自人多能性上胚层球体的CRISPR突变肾类器官对肾脏疾病进行建模。
Nat Commun. 2015 Oct 23;6:8715. doi: 10.1038/ncomms9715.
3
Nephron organoids derived from human pluripotent stem cells model kidney development and injury.源自人类多能干细胞的肾单位类器官可模拟肾脏发育和损伤。
使用人诱导多能干细胞衍生的肾类器官和HLA不匹配的外周血单个核细胞建立肾移植排斥反应模型:一种体外共培养系统。
Cell Mol Life Sci. 2025 Sep 2;82(1):333. doi: 10.1007/s00018-025-05867-7.
4
FGF9 treatment reduces off-target chondrocytes from iPSC-derived kidney organoids.成纤维细胞生长因子9(FGF9)治疗可减少诱导多能干细胞(iPSC)来源的肾脏类器官中的脱靶软骨细胞。
NPJ Regen Med. 2025 Aug 30;10(1):41. doi: 10.1038/s41536-025-00428-9.
5
Vascularization of kidney organoids: different strategies and perspectives.肾类器官的血管化:不同策略与展望。
Front Urol. 2024 May 21;4:1355042. doi: 10.3389/fruro.2024.1355042. eCollection 2024.
6
Autosomal Dominant Polycystic Kidney Disease: From Pathogenesis to Organoid Disease Models.常染色体显性多囊肾病:从发病机制到类器官疾病模型
Biomedicines. 2025 Jul 18;13(7):1766. doi: 10.3390/biomedicines13071766.
7
The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates.类器官在研究胃癌微环境中的免疫逃逸及筛选新型候选药物中的应用。
Mol Cancer. 2025 Apr 26;24(1):125. doi: 10.1186/s12943-025-02328-4.
8
PKD1 mutation perturbs morphogenesis in tubular epithelial organoids derived from human pluripotent stem cells.多囊肾病1基因(PKD1)突变扰乱了源自人类多能干细胞的肾小管上皮类器官的形态发生。
Sci Rep. 2025 Mar 26;15(1):10375. doi: 10.1038/s41598-025-94855-9.
9
Gene Editing: An Effective Tool for the Future Treatment of Kidney Disease.基因编辑:未来治疗肾脏疾病的有效工具。
J Inflamm Res. 2025 Mar 17;18:4001-4018. doi: 10.2147/JIR.S506760. eCollection 2025.
10
Microvascular aberrations found in human polycystic kidneys are an early feature in a Pkd1 mutant mouse model.在人类多囊肾中发现的微血管异常是Pkd1突变小鼠模型中的一个早期特征。
Dis Model Mech. 2025 Apr 1;18(4). doi: 10.1242/dmm.052024. Epub 2025 Apr 28.
Nat Biotechnol. 2015 Nov;33(11):1193-200. doi: 10.1038/nbt.3392.
4
Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis.人诱导多能干细胞来源的肾类器官包含多种细胞谱系,并可模拟人类肾发生。
Nature. 2015 Oct 22;526(7574):564-8. doi: 10.1038/nature15695. Epub 2015 Oct 7.
5
Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.多囊蛋白-1的成熟以剂量依赖的方式需要多囊蛋白-2。
J Clin Invest. 2015 Feb;125(2):607-20. doi: 10.1172/JCI76972. Epub 2015 Jan 9.
6
Altered trafficking and stability of polycystins underlie polycystic kidney disease.多囊蛋白的运输和稳定性改变是多囊肾病的基础。
J Clin Invest. 2014 Dec;124(12):5129-44. doi: 10.1172/JCI67273. Epub 2014 Nov 3.
7
Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells.重新定义后肾原基祖细胞的体内起源,使多能干细胞能够生成复杂的肾组织结构。
Cell Stem Cell. 2014 Jan 2;14(1):53-67. doi: 10.1016/j.stem.2013.11.010. Epub 2013 Dec 12.
8
Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.多囊肾病患者 PKD1 突变诱导多能干细胞中纤毛多囊蛋白-2 减少。
J Am Soc Nephrol. 2013 Oct;24(10):1571-86. doi: 10.1681/ASN.2012111089. Epub 2013 Sep 5.
9
Cerebral organoids model human brain development and microcephaly.类脑器官模型模拟人类大脑发育和小头畸形。
Nature. 2013 Sep 19;501(7467):373-9. doi: 10.1038/nature12517. Epub 2013 Aug 28.
10
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.可编程的双 RNA 引导的 DNA 内切酶在适应性细菌免疫中的作用。
Science. 2012 Aug 17;337(6096):816-21. doi: 10.1126/science.1225829. Epub 2012 Jun 28.